Literature DB >> 28935395

The role of Tec kinase signaling pathways in the development of Mallory Denk Bodies in balloon cells in alcoholic hepatitis.

N Afifiyan1, B Tillman1, B A French1, O Sweeny1, M Masouminia1, S Samadzadeh1, S W French2.   

Abstract

Several research strategies have been used to study the pathogenesis of alcoholic hepatitis (AH). These strategies have shown that various signaling pathways are the target of alcohol in liver cells. However, few have provided specific mechanisms associated with Mallory-Denk Bodies (MDBs) formed in Balloon cells in AH. The formation of MDBs in these hepatocytes is an indication that the mechanisms of protein quality control have failed. The MDB is the result of aggregation and accumulation of proteins in the cytoplasm of balloon degenerated liver cells. To understand the mechanisms that failed to degrade and remove proteins in the hepatocyte from patients suffering from alcoholic hepatitis, we investigated the pathways that showed significant up regulation in the AH liver biopsies compared to normal control livers (Liu et al., 2015). Analysis of genomic profiles of AH liver biopsies and control livers by RNA-seq revealed different pathways that were up regulated significantly. In this study, the focus was on Tec kinase signaling pathways and the genes that significantly interrupt this pathway. Quantitative PCR and immunofluorescence staining results, indicated that several genes and proteins are significantly over expressed in the livers of AH patients that affect the Tec kinase signaling to PI3K which leads to activation of Akt and its downstream effectors.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alcoholic hepatitis; Integrin; Mallory-Denk Bodies; PAK6; Tec

Mesh:

Substances:

Year:  2017        PMID: 28935395      PMCID: PMC5680109          DOI: 10.1016/j.yexmp.2017.09.001

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  33 in total

Review 1.  Integrin structure.

Authors:  M J Humphries
Journal:  Biochem Soc Trans       Date:  2000       Impact factor: 5.407

Review 2.  The genetics of Pak.

Authors:  Clemens Hofmann; Mikhail Shepelev; Jonathan Chernoff
Journal:  J Cell Sci       Date:  2004-09-01       Impact factor: 5.285

3.  α6β4 integrin, a master regulator of expression of integrins in human keratinocytes.

Authors:  Kristina R Kligys; Yvonne Wu; Susan B Hopkinson; Surinder Kaur; Leonidas C Platanias; Jonathan C R Jones
Journal:  J Biol Chem       Date:  2012-04-06       Impact factor: 5.157

4.  Kinase-independent functions for Itk in TCR-induced regulation of Vav and the actin cytoskeleton.

Authors:  Derek Dombroski; Richard A Houghtling; Christine M Labno; Patricia Precht; Aya Takesono; Natasha J Caplen; Daniel D Billadeau; Ronald L Wange; Janis K Burkhardt; Pamela L Schwartzberg
Journal:  J Immunol       Date:  2005-02-01       Impact factor: 5.422

Review 5.  The emerging importance of group II PAKs.

Authors:  Claire M Wells; Gareth E Jones
Journal:  Biochem J       Date:  2010-01-15       Impact factor: 3.857

Review 6.  Signaling by integrin receptors.

Authors:  C C Kumar
Journal:  Oncogene       Date:  1998-09-17       Impact factor: 9.867

7.  Genetic background effects of keratin 8 and 18 in a DDC-induced hepatotoxicity and Mallory-Denk body formation mouse model.

Authors:  Johannes Haybaeck; Cornelia Stumptner; Andrea Thueringer; Thomas Kolbe; Thomas M Magin; Michael Hesse; Peter Fickert; Oleksiy Tsybrovskyy; Heimo Müller; Michael Trauner; Kurt Zatloukal; Helmut Denk
Journal:  Lab Invest       Date:  2012-03-26       Impact factor: 5.662

8.  Expression and prognostic significance of p21-activated kinase 6 in hepatocellular carcinoma.

Authors:  Hongwei Chen; Jinlin Miao; Hongchen Li; Chunhua Wang; Junliang Li; Yong Zhu; Jianxin Wang; Xia Wu; Hongying Qiao
Journal:  J Surg Res       Date:  2014-01-29       Impact factor: 2.192

9.  TLR3/4 signaling is mediated via the NFκB-CXCR4/7 pathway in human alcoholic hepatitis and non-alcoholic steatohepatitis which formed Mallory-Denk bodies.

Authors:  Hui Liu; Jun Li; Brittany Tillman; Timothy R Morgan; Barbara A French; Samuel W French
Journal:  Exp Mol Pathol       Date:  2014-07-02       Impact factor: 3.362

10.  Ufmylation and FATylation pathways are downregulated in human alcoholic and nonalcoholic steatohepatitis, and mice fed DDC, where Mallory-Denk bodies (MDBs) form.

Authors:  H Liu; J Li; B Tillman; B A French; S W French
Journal:  Exp Mol Pathol       Date:  2014-06-02       Impact factor: 3.362

View more
  7 in total

Review 1.  Interplay of autophagy and cancer stem cells in hepatocellular carcinoma.

Authors:  Magdelyn Mei-Theng Wong; Hui-Yin Chan; Norazlin Abdul Aziz; Thamil Selvee Ramasamy; Jan-Jin Bong; Ewe Seng Ch'ng; Subasri Armon; Suat-Cheng Peh; Sin-Yeang Teow
Journal:  Mol Biol Rep       Date:  2021-04-24       Impact factor: 2.316

2.  Different roles of FAT10, FOXO1, and ADRA2A in hepatocellular carcinoma tumorigenesis in patients with alcoholic steatohepatitis (ASH) vs non-alcoholic steatohepatitis (NASH).

Authors:  Yue Jia; Barbara French; Brittany Tillman; Samuel French
Journal:  Exp Mol Pathol       Date:  2018-07-17       Impact factor: 3.362

Review 3.  The Role of FAT10 in Alcoholic Hepatitis Pathogenesis.

Authors:  Yue Jia; Ping Ji; Samuel W French
Journal:  Biomedicines       Date:  2020-07-01

4.  Advanced bioinformatic analysis and pathway prediction of NSCLC cells upon cisplatin resistance.

Authors:  A K M Nawshad Hossian; Fatema Tuz Zahra; Sagun Poudel; Camille F Abshire; Paula Polk; Jone Garai; Jovanny Zabaleta; Constantinos M Mikelis; George Mattheolabakis
Journal:  Sci Rep       Date:  2021-03-22       Impact factor: 4.379

Review 5.  Alcoholic-Hepatitis, Links to Brain and Microbiome: Mechanisms, Clinical and Experimental Research.

Authors:  Manuela G Neuman; Helmut Karl Seitz; Samuel W French; Stephen Malnick; Heidekazu Tsukamoto; Lawrence B Cohen; Paula Hoffman; Boris Tabakoff; Michael Fasullo; Laura E Nagy; Pamela L Tuma; Bernd Schnabl; Sebastian Mueller; Jennifer L Groebner; French A Barbara; Jia Yue; Afifiyan Nikko; Mendoza Alejandro; Tillman Brittany; Vitocruz Edward; Kylie Harrall; Laura Saba; Opris Mihai
Journal:  Biomedicines       Date:  2020-03-18

Review 6.  Role of spleen tyrosine kinase in liver diseases.

Authors:  Dhadhang Wahyu Kurniawan; Gert Storm; Jai Prakash; Ruchi Bansal
Journal:  World J Gastroenterol       Date:  2020-03-14       Impact factor: 5.742

Review 7.  Drug Discovery in Liver Disease Using Kinome Profiling.

Authors:  Bingting Yu; Ruslan Mamedov; Gwenny M Fuhler; Maikel P Peppelenbosch
Journal:  Int J Mol Sci       Date:  2021-03-05       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.